Möchten Sie immer auf dem neuesten Stand bleiben?

Late-Breaking Clinical Trial Results and Updated Global SYMPLICITY Registry Data Demonstrate Long-Term Results of RDN for Uncontrolled Hypertension DUBLIN and PARIS - May 22, 2019 - Investigators...

FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons DUBLIN - May 16, 2019 - Medtronic plc (NYSE:MDT), a...

Company to Proceed with Plans for Future Pivotal Study of New ICD System DUBLIN and SAN FRANCISCO - May 11, 2019 - Medtronic plc (NYSE:MDT) today announced findings from a pilot study of its...

Treatment Disparities Prevent Indicated Patients from Receiving Evidence-Recommended Life-Saving Devices DUBLIN and SAN FRANCISCO - May 10, 2019 - Three new studies show that patients who are...

DUBLIN - May 10, 2019 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for its fourth quarter and fiscal year 2019 on Thursday, May 23, 2019. A news release will be...

Acquisition Further Accelerates Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN - May 9, 2019 - Medtronic plc (NYSE:MDT), a...

DUBLIN - May 9, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of the SMILE study in The Lancet Diabetes & Endocrinology.1 The SMILE...

To Assess the Potential of Non-Opioid Treatment Options for Chronic Pain, Study Evaluates Pain Relief, Patient Function and Satisfaction DUBLIN and LAS VEGAS - May 7, 2019 - Medtronic plc...

Tablet-Based Device Manager Provides Portable and Secure Wireless Programming of Medtronic BlueSync(TM) Devices DUBLIN - May 2, 2019 - Medtronic plc (NYSE:MDT) today announced that the company...

Attain Stability(TM) Quad MRI SureScan(TM) Lead Designed for Precise Placement and Stability DUBLIN - May 1, 2019 - Medtronic plc (NYSE:MDT) announced it has received U.S. Food and Drug...